M&T Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
M&T Bank's REGN Position: Q2 2026 in Review
M&T Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 32% in Q2 2026, selling an estimated $1.48M and leaving 4,576 shares worth $2.85M. The position accounts for 0.01% of the portfolio, ranked #540.
M&T Bank first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $27.6M in Q1 2015. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- M&T Bank held 4,576 shares of Regeneron Pharmaceuticals worth $2.85M as of Q2 2026.
- M&T Bank sold 2,174 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.48M.
- Regeneron Pharmaceuticals made up 0.01% of M&T Bank's portfolio in Q2 2026, its #540 holding.
- M&T Bank first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- M&T Bank's Regeneron Pharmaceuticals position peaked at $27.6M in Q1 2015.
- 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.